Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 23;13:12055–12066. doi: 10.2147/OTT.S282053

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Zhang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

RAB14 was a direct downstream target of miR-338-3p. (A) Venn diagram of the predicted target genes in five databases (left), and schematic representation of the RAB14 3′-UTR containing the binding site for miR-338-3p (right). (B) The dual-luciferase reporter assay. (C) Western blot showed that miR-338-3p inhibited the expression of RAB14 protein. (D and E) EdU assay indicated that the knockdown of RAB14 significantly inhibited cell proliferation. (F) Transwell assay for migration. (G) Transwell assay for invasion. (H and I) RAB14, E-cadherin, and N-cadherin were detected by Western blot. *p < 0.05 and **p < 0.01.